AcceleTrial®

 

objective site data

Accelerate Clinical Trials with Site Intelligence, Patient Access, and Automation.

AcceleTrial® eliminates the guesswork in site feasibility, selection, and activation. Unlike traditional self-identification models, our AI-integrated platform leverages objective site expertise, experience, access to patients and performance data to match studies with the capable sites before outreach begins.

With access to a curated database of over 300,000 global investigators across thousands of sites, AcceleTrial® empowers sponsors to make data-driven decisions and initiate trials faster. By integrating intelligent automation, the platform streamlines feasibility assessments, site selection, and activation workflows, saving critical time and operational resources.

Ranked and indexed on real-world data, site profiles reflect historical performance, therapeutic specialization, enrollment reliability with verified access to patients, and protocol compatibility. This enables sponsors to focus efforts on partnering with sites to bring their trial to patients as a form of care, accelerating trial launch and enrollment.

When you begin with the right sites, you reach patients faster.
AcceleTrial® ensures you do just that—objectively, efficiently, and at scale.

 

Key Benefits

 

Objectively pair the right sites globally with objective site data on expertise, experience and patients to your clinical trials

 

Expediently launch the right sites to begin enrolling patients using AcceleTrial® automated “push and pull” structure presented in multiple languages

 

Accurately collect required documents using pre-filled templates and track activities in real-time

 

Immediately start using system – cloud-based solution requiring minimal IT set-up or training

 

Simply integrate AcceleTrial® with CTMS or other clinical trial systems

 
 

Download Resources

Brochure      Fact Sheet

 

Common Questions Guide

…